Monitor for future financial disclosures on IME's revenue contribution and any accretion/dilution. The acquisition is small and unlikely to move THRM materially in the near term.
Price Chart
Executive Summary
Gentherm acquired Innovative Medical Equipment (IME), a provider of the ThermaZone thermal therapy device, to expand its Medical business. The deal value was not disclosed, and the acquisition appears small relative to Gentherm's ~$1.5B annual revenue, making it a routine bolt-on acquisition with limited near-term financial impact.
Key Facts
- Acquired Innovative Medical Equipment (IME), maker of the ThermaZone non-opioid thermal therapy device.
- Deal value not disclosed; expected to be immaterial given Gentherm's ~$1.5B annual sales.
- Acquisition supports Gentherm's strategy to strengthen its Medical business and expand product portfolio.
- ThermaZone is a controlled hot-and-cold therapy solution for pain management and recovery.
Financial Impact
Undisclosed; likely immaterial relative to Gentherm's ~$1.5B annual revenue.
Risk Factors
- Integration risk if IME's operations do not align with Gentherm's global model.
- No financial details provided, making it difficult to assess value creation.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3331679 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 11, 2026 21d ago | 8-K | $38.85 $36.35 | ▼ −6.43% | ▼ −6.21% | $31.30 (−19.43%) |
Sep 10, 2026 22d ago | Press Release | $38.33 $37.66 | ▼ −1.75% | ▼ −1.25% | $31.30 (−18.34%) |
Aug 13, 2026 7w ago | EFFECT | $43.07 $40.67 | ▼ −5.57% | ▼ −3.61% | $31.30 (−27.33%) |
Jul 23, 2026 10w ago | 425 / 8-K | $45.61 $42.32 | ▼ −7.21% | ▼ −7.69% | $31.30 (−31.37%) |
Jul 23, 2026 10w ago | Press Release | $45.61 $42.32 | ▼ −7.21% | ▼ −7.69% | $31.30 (−31.37%) |
Jul 22, 2026 10w ago | Press Release | $45.61 $42.32 | ▼ −7.21% | ▼ −7.69% | $31.30 (−31.37%) |
Jul 20, 2026 10w ago | Press Release | $36.64 $42.07 | ▲ +14.82% | ▲ +16.05% | $31.30 (−14.57%) |
Jul 7, 2026 12w ago | Press Release | $34.48 $35.89 | ▲ +4.09% | ▲ +3.23% | $31.30 (−9.22%) |
Jul 2, 2026 13w ago | 425 | $33.88 $35.68 | ▲ +5.31% | ▲ +4.38% | $31.30 (−7.62%) |
Jul 2, 2026 13w ago | 8-K | $33.88 $35.68 | ▲ +5.31% | ▲ +4.38% | $31.30 (−7.62%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access